Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.

Item

http://www.wikidata.org/entity/Q41293822

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.

@en

type

Item

label

Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.

@en

prefLabel

Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.

@en

P1476

Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.

@en

P2093

Everson Nogoceke

http://www.w3.org/2001/XMLSchema#string

Felix Agakov

http://www.w3.org/2001/XMLSchema#string

Helen C Looker

http://www.w3.org/2001/XMLSchema#string

Natalie van Zuydam

http://www.w3.org/2001/XMLSchema#string

Nicola Barbarini

http://www.w3.org/2001/XMLSchema#string

Paul M McKeigue

http://www.w3.org/2001/XMLSchema#string

Riccardo Bellazzi

http://www.w3.org/2001/XMLSchema#string

SUMMIT Investigators

http://www.w3.org/2001/XMLSchema#string

Shona J Livingstone

http://www.w3.org/2001/XMLSchema#string

Tanja Zeller

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study.

Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study.

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial

Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease

Estimating improvement in prediction with matched case-control designs

Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register.

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

P2888

s00125-015-3535-6

P304

1363-1371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-015-3535-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273149219

http://www.w3.org/2001/XMLSchema#string

P698

25740695

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

biomarker